Investigators


Since our inception in 1997, TRIO has been at the forefront of cancer clinical research. A core component of our success in trial execution has been, and always will be, collaborations with engaged international Investigators. In our network, we:
TRIO’s investigator network is integral to how we conduct trials. When you participate in a trial, you play a critical role on our team and will receive:
You’ll also have the opportunity to join a group that’s led by Dr. Dennis Slamon, whose work has changed the treatment landscape in breast cancer!